Investors

CANTON, Mass., Nov. 9, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that the Company will host a conference call and live audio webcast on Thursday, November 12, 2015 at 8:00 a.m. ET. The Company will discuss its financial results for the third quarter of 2015 and provide a corporate update.  Topics in the corporate update will include: the recently announced FDA Tentative Approval for Xtampza™ ER and patent litigation with Purdue Pharma L.P. 

Conference Call Information: 

To access the conference call, please dial (866)864-3220 (U.S.) or (704)908-0478 (International). An audio webcast will be accessible from the Investor Relations section of the Company's website: http://www.collegiumpharma.com/. An archived webcast will be available on the Company's website approximately two hours after the event.

About Collegium Pharmaceutical, Inc. 

Collegium is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx^® technology platform for the treatment of chronic pain and other diseases. The DETERx oral drug delivery technology is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options.

CONTACT: Douglas Carlson
         Vice President, Corporate Development
         dcarlson@collegiumpharma.com